Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-135-7 | CAS number: 67801-15-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- Mar - May 2010
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions. Assigned reliability score of 2 on the basis that the test substance is being used for read-across.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol
- EC Number:
- 267-140-4
- EC Name:
- 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol
- Cas Number:
- 67801-20-1
- IUPAC Name:
- 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol
- Details on test material:
- IUPAC name : 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol
Molecular formulae : C14H24O
CAS number : 67801-20-1
EINECS number : 267-140-4
Description : Pale yellow liquid
Batch number : VE00071661
Purity : 96% (sum of isomers)
Date received : 29 January 2010
Expiry date : 10 June 2011
Storage conditions : Room temperature in the dark
Constituent 1
Method
- Target gene:
- The thymidine kinase heterozygote system, TK +/- to TK -/-.
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- The L5178Y TK+/- 3.7.2c mouse lymphoma cell line was obtained from Dr J Cole of the MRC Cell Mutation Unit at the University of Sussex, Brighton, UK. The cells were originally obtained from Dr D Clive of Burroughs Wellcome (USA) in October 1978 and were frozen in liquid nitrogen at that time.
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Male Sprague-Dawley rats: Three consecutive daily doses of phenobarbital/Beta-naphthoflavone (80/100 mg per kg per day). S9 was stored at approximately 196°C in a liquid nitrogen. Final concentration of S9 was 2% throughout the study.
- Test concentrations with justification for top dose:
- Concentrations assessed for mutation Frequency (ug/mL)
Test 1
4 hour -S9 (2.5, 5, 10, 20, 30)
4 Hour +S9 ( 5, 10, 20, 30, 40, 50)
24 Hour -S9 ( 2.5, 5, 10, 20, 30)
Test 2
4 Hour +S9 (10, 20, 30, 40, 45, 50, 55) - Vehicle / solvent:
- DMSO
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- The L5178Y TK+/- 3.7.2c mouse lymphoma cell line was obtained from Dr J Cole of the MRC Cell Mutation Unit at the University of Sussex, Brighton, UK. The cells were originally obtained from Dr D Clive of Burroughs Wellcome (USA) in October 1978 and were frozen in liquid nitrogen at that time.
Several days before starting the experiment, an exponentially growing stock culture of cells was set up so as to provide an excess of cells on the morning of the experiment. The cells were counted and processed to give 1 x 106 cells/ml in 10 ml aliquots in R10 medium in sterile plastic universals. The treatments were performed in duplicate (A + B), both with and without metabolic activation (S9-mix) at eight dose levels of the test material (2.5 to 60 µg/ml), vehicle and positive controls. To each universal was added 2 ml of S9-mix if required, 0.2 ml of the treatment dilutions, (0.2 ml for the positive control) and sufficient R0 medium to bring the total volume to 20 ml. The treatment vessels were incubated at 37°C for 4 hours with continuous shaking using an orbital shaker within an incubated hood.
At the end of the treatment period the cells were washed twice using R10 medium then resuspended in R20 medium at a cell density of 2 x 105 cells/ml. The cultures were incubated and subcultured every 24 hours for the expression period of two days, by counting and dilution to 2 x 105 cells/ml.
On Day 2 of each experiment, the cells were counted, diluted to 104 cells/ml and plated for mutant frequency (2000 cells/well) in selective medium containing 4 µg/ml 5 trifluorothymidine (TFT) in 96-well microtitre plates. Cells were also diluted to 10 cells/ml and plated (2 cells/well) for viability (%V) in non-selective medium. The daily cell counts were used to obtain a Percentage Relative Suspension Growth (%RSG) value that gives an indication of post treatment toxicity during the expression period as a comparison to the vehicle control, and when combined with the Viability (%V) data a Relative Total Growth (RTG) value.
Microtitre plates were scored using a magnifying mirror box after ten to fourteen days incubation. The number of positive wells (wells with colonies) was recorded together with the total number of scorable wells (normally 96 per plate). The numbers of small and large colonies seen in the TFT mutation plates were also recorded. Colonies are scored manually by eye using qualitative judgement. Large colonies are defined as those that cover approximately to of the surface of the well and are generally no more than one or two cells thick. In general, all colonies less than 25% of the average area of the large colonies are scored as small colonies. Small colonies are normally observed to be more than two cells thick. To assist the scoring of the TFT mutant colonies 0.025 ml of MTT solution (2.5 mg/ml in PBS) was added to each well of the mutation plates. The plates were incubated for approximately two hours. MTT is a vital stain that is taken up by viable cells and metabolised to give a brown/black colour, thus aiding the visualisation of the mutant colonies, particularly the small colonies. - Evaluation criteria:
- The normal range for mutant frequency per survivor is 50-200 x 10-6 for the TK+/- locus in L5178Y cells at this laboratory. Vehicle controls results should ideally be within this range.
Positive control chemicals should induce at least three to five fold increases in mutant frequency greater than the corresponding vehicle control.
Dose levels that have survival values (RTG) less than 10% are usually excluded from any statistical analysis, as any response they give would be considered to have no biological or toxicological relevance.
For a test material to demonstrate a mutagenic response it must produce a statistically significant increase in the induced mutant frequency (IMF) over the concurrent vehicle mutant frequency value. Following discussions at an International Workshop on Genotoxicity Test Procedures in Plymouth, UK, 2002 (Moore et al 2003) it was felt that the IMF must exceed some value based on the global background MF for each method (agar or microwell). This Global Evaluation Factor (GEF) value was set following a further meeting of the International Workshop in Aberdeen, Scotland, 2003 (Moore et al 2006) at 126 x 10-6 for the microwell method. Therefore any test material dose level that has a mutation frequency value that is greater than the corresponding vehicle control by the GEF of 126 x 10-6 will be considered positive.
However, if a test material produces a modest increase in mutant frequency, which only marginally exceeds the GEF value and is not reproducible or part of a dose-related response, then it may be considered to have no toxicological significance. Conversely, when a test material induces modest reproducible increases in the mutation frequencies that do not exceed the GEF value then scientific judgement will be applied. If the reproducible responses are significantly dose-related and include increases in the absolute numbers of mutant colonies then they may be considered to be toxicologically significant. - Statistics:
- The International Workshop on Genotoxicity Test Procedures in Plymouth, UK, 2002 (Moore et al 2003) stated that the IMF must exceed some value based on the global background MF. This Global Evaluation Factor (GEF) value was set following a further meeting of the International Workshop in Aberdeen, Scotland, 2003 (Moore et al 2006) at 126 x 10-6 for the microwell method. Therefore any test material dose level that has a mutation frequency value that is greater than the corresponding vehicle control by the GEF of 126 x 10-6 will be considered positive.
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (4 hour -S9 at 40ug/ml, 4 hour +S9 at 60ug/ml, 24 hour _S9 at 40
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: strain/cell type: L5178Y mouse lymphoma cell line
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table1 Summary of Results
Experiment 1
Treatment (µg/ml) |
4-Hours-S-9 |
Treatment (µg/ml) |
4-Hours+S-9 |
||||||||
|
% |
RTG |
MF§ |
|
% |
RTG |
MF§ |
||||
0 |
|
100 |
1.00 |
64.39 |
|
0 |
|
100 |
1.00 |
75.58 |
|
2.5 |
|
111 |
1.15 |
71.60 |
|
2.5 |
Ø |
107 |
|
|
|
5 |
|
107 |
1.07 |
60.82 |
|
5 |
|
101 |
0.96 |
106.08 |
|
10 |
|
102 |
1.00 |
65.22 |
|
10 |
|
93 |
1.08 |
79.57 |
|
20 |
|
84 |
0.92 |
71.56 |
|
20 |
|
107 |
1.00 |
82.89 |
|
30 |
|
25 |
0.26 |
73.99 |
|
30 |
|
99 |
0.89 |
101.72 |
|
40 |
Ø |
0 |
|
|
|
40 |
|
85 |
0.78 |
108.88 |
|
50 |
Ø |
0 |
|
|
|
50 |
|
43 |
0.50 |
67.74 |
|
60 |
Ø |
0 |
|
|
|
60 |
Ø |
0 |
|
|
|
Linear trend |
|
NS |
Linear trend |
|
NS |
||||||
EMS |
|
|
|
|
|
CP |
|
|
|
|
|
400 |
|
85 |
0.60 |
812.98 |
|
2 |
|
66 |
0.39 |
1000.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Experiment 2
Treatment (µg/ml) |
24-Hours-S-9 |
Treatment (µg/ml) |
4-Hours+S-9 |
||||||||
|
% |
RTG |
MF§ |
|
% |
RTG |
MF§ |
||||
0 |
|
100 |
1.00 |
65.51 |
|
0 |
|
100 |
1.00 |
79.90 |
|
2.5 |
|
97 |
1.15 |
84.15 |
|
2.5 |
Ø |
91 |
|
|
|
5 |
|
92 |
0.96 |
88.37 |
|
5 |
Ø |
86 |
|
|
|
10 |
|
96 |
0.94 |
101.71 |
|
10 |
|
82 |
0.89 |
85.01 |
|
20 |
|
56 |
0.53 |
71.39 |
|
20 |
|
83 |
0.84 |
87.03 |
|
30 |
|
33 |
0.27 |
76.94 |
|
30 |
|
77 |
0.99 |
56.41 |
|
40 |
Ø |
|
|
|
|
40 |
|
68 |
0.70 |
77.86 |
|
50 |
Ø |
|
|
|
|
45 |
|
53 |
0.58 |
95.58 |
|
60 |
Ø |
|
|
|
|
50 |
|
41 |
0.35 |
66.56 |
|
|
|
|
|
|
|
55 |
|
8 |
0.12 |
108.62 |
|
|
|
|
|
|
|
60 |
Ø |
1 |
|
|
|
Linear trend |
|
NS |
Linear trend |
|
NS |
||||||
EMS |
|
|
|
|
|
CP |
|
|
|
|
|
150 |
|
59 |
0.49 |
1421.09 |
|
2 |
|
61 |
0.30 |
821.39 |
|
Applicant's summary and conclusion
- Conclusions:
- The test material did not induce any toxicologically significant increases in the mutant frequency at the TK +/- locus in L5178Y cells and is therefore considered to be non-mutagenic under the conditions of the test.
- Executive summary:
The test material did not induce any toxicologically significant increases in the mutant frequency at the TK +/- locus in L5178Y cells and is therefore considered to be non-mutagenic under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.